galantamine has been researched along with Age-Related Memory Disorders in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (32.14) | 29.6817 |
| 2010's | 17 (60.71) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, YH; Lee, YS; Nam, SO; Park, DH; Ryu, JH | 1 |
| Boonyarat, C; Reubroycharoen, P; Thiratmatrakul, S; Tohda, M; Vajragupta, O; Waiwut, P; Yenjai, C | 1 |
| Darekar, MN; Gurjar, AS; Ooi, L; Yeong, KY | 1 |
| Celik Topkara, K; Cetinkaya, A; Demir, S; Kilinc, E; Saylan, A | 1 |
| Brinza, I; El-Kashak, W; Eldahshan, OA; Hritcu, L; Raey, MAE | 1 |
| Boulouard, M; Dauphin, F; Freret, T; Hamidouche, K; Lecouflet, P; Lelong-Boulouard, V | 1 |
| Ali, EHA; Arafa, NMS; Hassan, MK | 1 |
| Engberg, ME; Ficken, M; Johns, BE; Philpot, RM; Wecker, L | 1 |
| Choi, JH; Hwang, IK; Jung, HY; Kim, JH; Kim, W; Nam, SM; Won, MH; Yoo, DY; Yoon, YS | 1 |
| Ahn, IS; Carroll, BJ; Hwang, TY; Kang, HS; Kim, DK; Ku, HM; Lee, Y; Myung, W; Song, J; Woo, SY | 1 |
| Akaishi, T | 1 |
| Callaerts-Vegh, Z; D'Hooge, R; De Maeyer, JH; Lo, AC; Schuurkes, JA; Vermaercke, B | 1 |
| Bogo, MR; Capiotti, KM; Da Silva, RS; De Moraes, DA; Kist, LW; Menezes, FP | 1 |
| Babri, S; Mahmoudi, J; Sadigh-Eteghad, S; Talebi, M | 1 |
| Abe, K; Feng, T; Fukui, Y; Hishikawa, N; Morihara, R; Nakano, Y; Ohta, Y; Shang, J; Sun, Z; Yamashita, T; Zhai, Y | 1 |
| Andrews, S; Faught, E; Griffith, HR; LeBron Paige, A; Martin, R; Ware, J; Welty, T | 1 |
| Benetti, F; Bonini, JS; Cammarota, M; Izquierdo, I; Mello, PB; Monteiro, S | 1 |
| Kano, M; Kurinami, H; Morishita, R; Niisato, K; Rakugi, H; Sato, N; Shinohara, M; Takeda, S; Takeuchi, D | 1 |
| Bogo, MR; Bonan, CD; da Silva, RS; de Lima, MN; Dornelles, AS; Perez, VP; Schröder, N; Vedana, G | 1 |
| Cedazo-Mínguez, A; Gil-Bea, FJ; Mateos, L; Ramírez, MJ; Solas, M; Winblad, B | 1 |
| Ilavazhagan, G; Maiti, P; Muthuraju, S; Pati, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P | 1 |
| Kanno, T; Nishizaki, T; Shimizu, T; Tanaka, A; Yaguchi, T | 1 |
| Scheltens, P; Verhey, FR; Visser, PJ | 1 |
| Dimitrova, DS; Getova-Spassova, DP | 1 |
| Chilovi, BV; Costardi, D; Franzoni, S; Padovani, A; Rozzini, L; Trabucchi, M | 1 |
| Arias, E; García, AG; López, MG; Lorrio, S; Roda, JM; Sobrado, M | 1 |
| Furukawa, H; Nabeshima, T; Nitta, A; Noda, Y; Wang, D; Zhou, Y | 1 |
| Wong, VS | 1 |
1 review(s) available for galantamine and Age-Related Memory Disorders
| Article | Year |
|---|---|
[Memory-enhancing drugs].
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP Response Element-Binding Protein; Donepezil; Drug Discovery; Extracellular Signal-Regulated MAP Kinases; Galantamine; Hippocampus; Humans; Indans; Long-Term Potentiation; Memantine; Memory; Memory Disorders; Molecular Targeted Therapy; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Synaptic Transmission | 2014 |
4 trial(s) available for galantamine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Cognitive subdomain responses to galantamine in Alzheimer's disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Executive Function; Female; Galantamine; Humans; Male; Memory Disorders; Neuropsychological Tests; Severity of Illness Index; Treatment Outcome | 2014 |
The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.
Topics: Adult; Anticonvulsants; Cholinesterase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Epilepsy; Female; Galantamine; Humans; Male; Memory Disorders; Mental Recall; Middle Aged; Neuropsychological Tests; Nootropic Agents | 2008 |
Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Female; Follow-Up Studies; Galantamine; Humans; Lactones; Male; Memory Disorders; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Piracetam; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Sulfones | 2005 |
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
Topics: Activities of Daily Living; Aged; Cholinesterase Inhibitors; Cognition Disorders; Combined Modality Therapy; Computer-Assisted Instruction; Donepezil; Female; Galantamine; Humans; Indans; Intelligence; Longitudinal Studies; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Nootropic Agents; Orientation; Phenylcarbamates; Piperidines; Problem Solving; Retrospective Studies; Rivastigmine; Software; Treatment Outcome | 2007 |
23 other study(ies) available for galantamine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Coumarins; Disease Models, Animal; Enzyme Activation; Male; Memory; Memory Disorders; Mice; Mice, Inbred ICR; Protein Binding; Pyrrolidines; Scopoletin; Structure-Activity Relationship | 2014 |
Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Butyrylcholinesterase; Carbazoles; Cell Line; Cholinesterase Inhibitors; Electrophorus; Humans; Male; Memory Disorders; Mice; Molecular Docking Simulation; Oxidative Stress; Tacrine | 2014 |
In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophorus; Female; Horses; Imidazoles; Male; Maze Learning; Memory Disorders; Mice; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship | 2018 |
Therapeutic effects of carvacrol on beta-amyloid-induced impairments in in vitro and in vivo models of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Galantamine; Hippocampus; Humans; Memory Disorders; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Rats; Superoxide Dismutase; Thymol | 2022 |
Sweroside Ameliorated Memory Deficits in Scopolamine-Induced Zebrafish (
Topics: Acetylcholinesterase; Animals; Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Brain; Cholinergic Agents; Galantamine; Glucose; Hypnotics and Sedatives; Imipramine; Iridoid Glucosides; Maze Learning; Memory Disorders; Oxidative Stress; Scopolamine; Sugars; Zebrafish | 2022 |
Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse.
Topics: Allosteric Regulation; Alzheimer Disease; Aniline Compounds; Animals; Cholinesterase Inhibitors; Galantamine; Male; Memory Disorders; Mice; Nicotinic Antagonists; Piperidines; Receptors, Nicotinic; Receptors, Serotonin, 5-HT4; Scopolamine; Serotonin 5-HT4 Receptor Agonists | 2017 |
Canagliflozin prevents scopolamine-induced memory impairment in rats: Comparison with galantamine hydrobromide action.
Topics: Acetylcholinesterase; Animals; Canagliflozin; Galantamine; Hippocampus; Hypoglycemic Agents; Male; Maze Learning; Memory; Memory Disorders; Rats; Rats, Wistar; Scopolamine | 2017 |
Spatial memory deficits in mice induced by chemotherapeutic agents are prevented by acetylcholinesterase inhibitors.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Behavior, Animal; Cholinesterase Inhibitors; Cyclophosphamide; Donepezil; Doxorubicin; Female; Galantamine; Memory Disorders; Mice; Mice, Inbred BALB C; Spatial Memory | 2019 |
Effects of luteolin on spatial memory, cell proliferation, and neuroblast differentiation in the hippocampal dentate gyrus in a scopolamine-induced amnesia model.
Topics: Acetylcholinesterase; Amnesia; Animals; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Proliferation; Cholinesterase Inhibitors; Dentate Gyrus; Doublecortin Protein; Galantamine; Lipid Peroxidation; Luteolin; Male; Maze Learning; Memory Disorders; Neurogenesis; Neuroprotective Agents; Rats; Scopolamine | 2013 |
SSP-002392, a new 5-HT4 receptor agonist, dose-dependently reverses scopolamine-induced learning and memory impairments in C57Bl/6 mice.
Topics: Animals; Anxiety; Avoidance Learning; Benzofurans; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Galantamine; Male; Maze Learning; Memory Disorders; Mice, Inbred C57BL; Nootropic Agents; Piperidines; Random Allocation; Receptors, Serotonin, 5-HT4; Scopolamine; Serotonin 5-HT4 Receptor Agonists | 2014 |
Hyperglycemia induces memory impairment linked to increased acetylcholinesterase activity in zebrafish (Danio rerio).
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Avoidance Learning; Brain; Cholinesterase Inhibitors; Disease Models, Animal; Escape Reaction; Female; Galantamine; Gene Expression Regulation; Glucose; Glucose Transporter Type 3; Hyperglycemia; Male; Memory Disorders; Motor Activity; Receptor, Insulin; Zebrafish | 2014 |
Effect of alpha-7 nicotinic acetylcholine receptor activation on beta-amyloid induced recognition memory impairment. Possible role of neurovascular function.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Disease Models, Animal; Galantamine; Laser-Doppler Flowmetry; Male; Memory Disorders; Mice, Inbred BALB C; Neuropsychological Tests; Neurovascular Coupling; Peptide Fragments; Quinuclidines; Recognition, Psychology; Reproducibility of Results; Time Factors; Treatment Outcome | 2015 |
Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Carotid Stenosis; Cholinesterase Inhibitors; Disease Models, Animal; Galantamine; Gene Expression Regulation; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Models, Cardiovascular; Plaque, Amyloid; Postural Balance; Psychomotor Performance; Receptors, Nicotinic; White Matter | 2016 |
Early postnatal maternal deprivation in rats induces memory deficits in adult life that can be reversed by donepezil and galantamine.
Topics: Acetylcholine; Acetylcholinesterase; Aging; Animals; Animals, Newborn; Brain; Disease Models, Animal; Donepezil; Female; Galantamine; Hippocampus; Indans; Learning Disabilities; Male; Maternal Deprivation; Memory Disorders; Neuropsychological Tests; Nootropic Agents; Piperidines; Rats; Rats, Wistar; Social Behavior | 2009 |
Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Ventricles; Cognition Disorders; Disease Models, Animal; Galantamine; Hippocampus; Injections, Intraventricular; Long-Term Potentiation; Male; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Neurotoxins; Nootropic Agents; Peptide Fragments | 2009 |
Iron leads to memory impairment that is associated with a decrease in acetylcholinesterase pathways.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Animals, Newborn; Brain; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Female; Ferrous Compounds; Galantamine; Gene Expression Regulation, Enzymologic; Male; Memory Disorders; Muscarinic Agonists; Neural Pathways; Oxotremorine; Pregnancy; Rats; Reaction Time; Recognition, Psychology; Statistics, Nonparametric | 2010 |
Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation.
Topics: Acetylcholine; Animals; Antibodies, Monoclonal; Brain-Derived Neurotrophic Factor; Cholinergic Fibers; Cholinesterase Inhibitors; Cytoskeletal Proteins; Female; Galantamine; Hippocampus; Immunotoxins; Male; Maze Learning; Memory; Memory Disorders; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Muscarinic; Receptors, Nicotinic; Ribosome Inactivating Proteins, Type 1; RNA, Messenger; Saporins | 2011 |
Possible role of cholinesterase inhibitors on memory consolidation following hypobaric hypoxia of rats.
Topics: Acetylcholine; Air Pressure; Altitude Sickness; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Galantamine; Hypoxia, Brain; Male; Maze Learning; Memory; Memory Disorders; Physostigmine; Rats; Rats, Sprague-Dawley; Time Factors; Treatment Outcome | 2011 |
8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid and its diastereomers improve age-related cognitive deterioration.
Topics: Aging; Animals; Caprylates; Cholinesterase Inhibitors; Cognition Disorders; Galantamine; Male; Memory Disorders; Mice | 2012 |
Effects of galantamine and donepezil on active and passive avoidance tests in rats with induced hypoxia.
Topics: Animals; Avoidance Learning; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Galantamine; Hypoxia, Brain; Indans; Male; Memory; Memory Disorders; Piperidines; Rats; Rats, Wistar; Sodium Nitrite; Time Factors | 2006 |
Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils.
Topics: Animals; Apoptosis; Brain Ischemia; Carotid Artery, Common; Caspase 3; Galantamine; Gerbillinae; Hippocampus; Male; Mecamylamine; Memory Disorders; Pyramidal Cells; Reperfusion Injury; Superoxide Dismutase | 2007 |
Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Galantamine; Learning Disabilities; Male; Memory Disorders; Mice; Mice, Inbred ICR; Microdialysis; Nootropic Agents; Phencyclidine; Reaction Time; Receptors, Dopamine D1; Receptors, Nicotinic; Risperidone; Space Perception | 2007 |
Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial.
Topics: Alzheimer Disease; Caregivers; Clinical Trials as Topic; Disability Evaluation; Galantamine; Humans; Memory Disorders; Neuropsychological Tests; Nootropic Agents; Outcome Assessment, Health Care; Quality of Life; Respiratory Tract Infections; Risk Assessment; Speech Disorders; Treatment Outcome; Verbal Behavior; Vomiting | 2007 |